Animation - Targeted Therapy in Non-Small Cell Lung Cancer
This animation provides an overview of targeted therapy for the treatment of non-small cell lung cancer (NSCLC). Targeted therapy is a cancer treatment directed towards specific mutations that drive cancer to grow and spread. Watch to learn about targeted therapy for common gene mutations such as EGFR, ALK, ROS1, and BRAF. You may qualify for targeted therapy based on the results of biomarker testing. This testing allows doctors to prescribe treatment that is tailored to your individual cancer. Be sure to ask your doctor about biomarker testing and targeted therapy. Targeted therapy offers hope and can make an important difference in your health outcomes.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Please rate this content:
Animation - Targeted Therapy in NSCLC
Slide Show - Targeted Therapy in NSCLC
1.
What is targeted therapy for lung cancer?
2.
What targeted therapies are used for people with the EGFR mutation?
3.
What targeted therapies are used for people with the ALK mutation?
4.
What targeted therapies are used for people with the ROS1 mutation?
5.
What is the importance of combination therapies for BRAF?
6.
What is the future of combination therapy for lung cancer?
7.
Can biomarker testing help identify clinical trial opportunities for me?
8.
How can communities of color increase their participation in clinical trials?
